Surmodics' (SRDX) New Device to Boost Its Thrombectomy Platform
https://www.zacks.com/stock/news/2214295/surmodics-srdx-new-device-to-boost-its-thrombectomy-platform?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2214295
Jan 23, 2024 - Surmodics (SRDX) new addition to its Pounce Thrombectomy Platform is recommended for use in vessels with a diameter between 2 mm and 4 mm for clot removal.
0
Why Integer (ITGR) is a Top Value Stock for the Long-Term
https://www.zacks.com/stock/news/2213450/why-integer-itgr-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2213450
Jan 22, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
ITGR vs. EW: Which Stock Is the Better Value Option?
https://www.zacks.com/stock/news/2212931/itgr-vs-ew-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2212931
Jan 19, 2024 - ITGR vs. EW: Which Stock Is the Better Value Option?
0
Nevro's (NVRO) SCS Therapy Gets Positive Coverage Update
https://www.zacks.com/stock/news/2212901/nevro-s-nvro-scs-therapy-gets-positive-coverage-update?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2212901
Jan 19, 2024 - Nevro's (NVRO) latest announcement of a positive coverage update from Carelon Healthcare for PDN treatment is likely to serve a wider patient pool.
0
Reasons to Retain DexCom (DXCM) Stock in Your Portfolio for Now
https://www.zacks.com/stock/news/2212771/reasons-to-retain-dexcom-dxcm-stock-in-your-portfolio-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2212771
Jan 19, 2024 - DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
0
ClearPoint Neuro (CLPT) Gets FDA's Nod for SmartFrame OR System
https://www.zacks.com/stock/news/2211532/clearpoint-neuro-clpt-gets-fda-s-nod-for-smartframe-or-system?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2211532
Jan 17, 2024 - ClearPoint Neuro's (CLPT) receipt of the FDA's latest approval is likely to serve a wider patient pool than its legacy portfolio.
0
PacBio's (PACB) New PanDNA Kit Ready to Boost DNA Extraction
https://www.zacks.com/stock/news/2210985/pacbio-s-pacb-new-pandna-kit-ready-to-boost-dna-extraction?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2210985
Jan 16, 2024 - PacBio's (PACB) new offering, PanDNA kit, is likely to help researchers effectively extract DNA optimized for HiFi sequencing. This versatile Nanobind kit is expected to be available in February 2024.
0
Here's Why You Should Retain Masimo (MASI) Stock for Now
https://www.zacks.com/stock/news/2210710/here-s-why-you-should-retain-masimo-masi-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2210710
Jan 16, 2024 - Masimo's (MASI) R&D activities raise optimism about the stock.
0
Veeva Systems (VEEV) Offerings Adopted by SK Life Science
https://www.zacks.com/stock/news/2210243/veeva-systems-veev-offerings-adopted-by-sk-life-science?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2210243
Jan 15, 2024 - Veeva Systems' (VEEV) Vault Validation Management is expected to aid SK Life Science to accelerate validation processes for increased inspection readiness.
0
Stryker's (SYK) New Tech Aims to Improve Surgeon's Efficiency
https://www.zacks.com/stock/news/2210235/stryker-s-syk-new-tech-aims-to-improve-surgeon-s-efficiency?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2210235
Jan 15, 2024 - Stryker's (SYK) Blueprint Mixed Reality Guidance system aims to benefit shoulder arthroplasty surgeons by improving efficiency and minimizing errors.
0